A Meddevicetracker report predicts the global sales of spinal cord stimulation systems will reach $2.4 billion by 2021 with a 6% compound annual growth rate. The largest market growth will continue to come from the dominant market, the US, because of the increasing demand for pain-management solutions from an expanding aging and obese population, more regulatory approvals of SCS products and an increasing interest in the use of the devices as an alternative treatment.
Report predicts growth for global spinal cord stimulation systems sales
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.